These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Human papillomavirus infection and cervical cancer prevention in Japan and Korea. Konno R; Shin HR; Kim YT; Song YS; Sasagawa T; Inoue M; Park JS Vaccine; 2008 Aug; 26 Suppl 12():M30-42. PubMed ID: 18945412 [TBL] [Abstract][Full Text] [Related]
7. Cervical cancer screening of women living with HIV infection: a must in the era of antiretroviral therapy. Franceschi S; Jaffe H Clin Infect Dis; 2007 Aug; 45(4):510-3. PubMed ID: 17638204 [TBL] [Abstract][Full Text] [Related]
8. Human papillomavirus anogenital disease in HIV-infected individuals. Chin-Hong PV; Palefsky JM Dermatol Ther; 2005; 18(1):67-76. PubMed ID: 15842614 [TBL] [Abstract][Full Text] [Related]
9. Human papillomavirus infection and cervical cancer prevention in India, Bangladesh, Sri Lanka and Nepal. Sankaranarayanan R; Bhatla N; Gravitt PE; Basu P; Esmy PO; Ashrafunnessa KS; Ariyaratne Y; Shah A; Nene BM Vaccine; 2008 Aug; 26 Suppl 12():M43-52. PubMed ID: 18945413 [TBL] [Abstract][Full Text] [Related]
10. Epidemiology of human papillomavirus infection and cervical cancer and future perspectives in Hong Kong, Singapore and Taiwan. Tay SK; Ngan HY; Chu TY; Cheung AN; Tay EH Vaccine; 2008 Aug; 26 Suppl 12():M60-70. PubMed ID: 18945415 [TBL] [Abstract][Full Text] [Related]
11. Predictors of atypical squamous cell of undetermined significance cervical cytology with high-risk human papilloma virus genotypes. Musa J; Taiwo B; Goldsmith S; Sutton S; Berzins B; Murphy RL Arch Gynecol Obstet; 2011 Feb; 283(2):343-8. PubMed ID: 20229315 [TBL] [Abstract][Full Text] [Related]
12. Cervical cancer screening in the early post vaccine era. Waxman AG Obstet Gynecol Clin North Am; 2008 Dec; 35(4):537-48; vii. PubMed ID: 19061815 [TBL] [Abstract][Full Text] [Related]
13. Prevalence and risk factors for human papillomavirus DNA in cervical cytology. Kasap B; Yetimalar H; Keklik A; Yildiz A; Cukurova K; Soylu F Eur J Obstet Gynecol Reprod Biol; 2011 Nov; 159(1):168-71. PubMed ID: 21764503 [TBL] [Abstract][Full Text] [Related]
14. Human papillomavirus and Papanicolaou tests screening interval recommendations in the United States. Roland KB; Soman A; Benard VB; Saraiya M Am J Obstet Gynecol; 2011 Nov; 205(5):447.e1-8. PubMed ID: 21840492 [TBL] [Abstract][Full Text] [Related]
15. Human papillomavirus and cervical disease in adolescents. Guido R Clin Obstet Gynecol; 2008 Jun; 51(2):290-305. PubMed ID: 18463460 [TBL] [Abstract][Full Text] [Related]
16. Australian women's needs and preferences for information about human papillomavirus in cervical screening. McCaffery K; Irwig L J Med Screen; 2005; 12(3):134-41. PubMed ID: 16156944 [TBL] [Abstract][Full Text] [Related]
18. Epidemiology and prevention of cervical cancer in Indonesia, Malaysia, the Philippines, Thailand and Vietnam. Domingo EJ; Noviani R; Noor MR; Ngelangel CA; Limpaphayom KK; Thuan TV; Louie KS; Quinn MA Vaccine; 2008 Aug; 26 Suppl 12():M71-9. PubMed ID: 18945416 [TBL] [Abstract][Full Text] [Related]
19. Human papillomavirus testing for primary screening of cervical cancer precursors. Ratnam S; Franco EL; Ferenczy A Cancer Epidemiol Biomarkers Prev; 2000 Sep; 9(9):945-51. PubMed ID: 11008913 [TBL] [Abstract][Full Text] [Related]
20. Periodic health examination, 1995 update: 1. Screening for human papillomavirus infection in asymptomatic women. Canadian Task Force on the Periodic Health Examination. Johnson K CMAJ; 1995 Feb; 152(4):483-93. PubMed ID: 7859196 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]